Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates.
Clicks: 268
ID: 12261
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
76.2
/100
268 views
217 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #78 of 157 articles by views in Environment international
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 157 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Pharmaceuticals and personal care products are an integral part of societal health yet their presence in various environmental compartments, including treated wastewaters, has sparked concerns towards possible human and ecological health effects. The current study aims to characterize human health risks posed by ten pharmaceuticals quantified in wastewater treatment plant effluents where water is reused mainly for landscape irrigation. Receptors were identified as children playing in green areas, adult landscape workers, and adult users of athletic and golf courses irrigated by treated wastewater. The human health risk assessment model exhibited safe exposure (RQ < 1) to all pharmaceuticals for all receptors through both dermal and ingestion exposure pathways. RQs were highest for the landscape worker followed by children playing in green areas and then adult using the athletic fields. RQs were highest to lowest in the following order of pharmaceuticals: acetaminophen, metoprolol, ciprofloxacin, erythromycin, ofloxacin, sulfadiazine, sulfamethoxazole, sulfapyridine, risperidone, and sulfamethazine. Such risk assessment findings aid in supporting decisions to optimize wastewater treatment and reuse strategies, as well as safeguard public and environmental health.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (93 words).
Try re-searching for a better abstract.
| Reference Key |
semerjian2018humanenvironment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Semerjian, Lucy;Shanableh, Abdallah;Semreen, Mohammad H;Samarai, Mufid; |
| Journal | Environment international |
| Year | 2018 |
| DOI |
S0160-4120(18)31011-0
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.